{
    "SPADE_N_03155": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2002/0115602 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2002_0115602_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2002-8-22",
                "Family Info": "US6809181,WO2001092309A2,WO2001092309A3",
                "Patent Title": "Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide.",
                "Abstract": "The present invention relates a novel antimicrobial peptide HBD-3 and derivatives thereof as well as the gene encoding the peptide. The invention further relates to methods of use of the HBD-3 peptide including a method of inhibiting microbial growth by administering an effective amount of the HBD-3 peptide alone or in combinination with other antimicrobial agents or antibiotics. In addition, the immunomodulatory properties of the HBD-3 peptide also facilitate the manipulation of the immune response, i.e., as a chemoattractant for immature dentritic cells or memory T cells."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_03155",
            "Peptide Name": "Human beta-defensin 3 (BD-3, hBD-3; Hbd3; Beta-defensin 103; Human, mammals, animals)",
            "Source": "Homo sapiens (Human)",
            "Family": "Belongs to the beta-defensin family",
            "Gene": "DEFB103A AND DEFB103",
            "Sequence": "GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK",
            "Sequence Length": 45,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P81534",
                "http://www.uniprot.org/uniprot/Q8NFG6",
                "http://www.uniprot.org/uniprot/Q9NPF6"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal"
            ],
            "Target Organism": "[Ref.11085990]Gram-negative bacteria:Escherichia coli DSM1103 (MIC=9.4 µg/ml), Klebsiella pneumoniae DSM681 (MIC=25 µg/ml), Pseudomonas aeruginosa DSM1128 (MIC=18.75 µg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC25923 (MIC=4.7 µg/ml), Streptococcus pneumoniae DSM11865 (MIC=4.7 µg/ml).",
            "Hemolytic Activity": "[Ref.11085990] It has 9% hemolysis at 250 µg/ml, 15% hemolysis at 500 µg/ml against human erythrocytes.",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Contains three disulfide bonds and a short helical segment preceding a three-stranded antiparallel beta-sheet.",
            "Formula": "C216H377N75O59S6",
            "Mass": 5161.16,
            "PI": 10.08,
            "Net Charge": 11,
            "Hydrophobicity": -0.7,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Exhibits antimicrobial activity against Gram-positive bacteria and the Gram-negative bacteria and the yeast C.albicans. Kills multiresistant S. aureus and vancomycin-resistant E. faecium. Has hemolytic activity.",
            "Tissue specificity": "Highly expressed in skin and tonsils, and to a lesser extent in trachea, uterus, kidney, thymus, adenoid, pharynx and tongue. Low expression in salivary gland, bone marrow, colon, stomach, polyp and larynx. No expression in small intestine.",
            "Induction": "By bacterial infection and by IFNG/IFN-gamma.",
            "PTM": "Contains three disulfide bonds 11-40; 18-33; 23-41.",
            "Literature": [
                {
                    "Title": "Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28 differences in disulfide formation and biological activity among human beta-defensins.",
                    "Pubmed ID": "15625724",
                    "Reference": "Biopolymers. 2005;80(1)34-49.",
                    "Author": "Schulz A, Klüver E, Schulz-Maronde S, Adermann K.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15625724"
                },
                {
                    "Title": "Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic.",
                    "Pubmed ID": "11085990",
                    "Reference": "J Biol Chem. 2001 Feb 23;276(8)5707-5713.",
                    "Author": "Harder J, Bartels J, Christophers E, Schroder JM.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11085990"
                }
            ],
            "Frequent Amino Acids": "RCK",
            "Absent Amino Acids": "DFHMOUW",
            "Basic Residues": 13,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 12,
            "Polar Residues": 31,
            "Positive Residues": 13,
            "Negative Residues": 2,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_08033",
                    "Similarity": 1.0,
                    "Sequence": "MRIHYLLFTLLFLFLVPVPGHGGIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_00868",
                    "Similarity": 1.0,
                    "Sequence": "MRIHYLLFALLFLFLVPVPGHGGIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_04295",
                    "Similarity": 1.0,
                    "Sequence": "GIINTLQKYYRVRGGRAVLSLPKEEQIGKSTRGRKRRKK"
                }
            ]
        }
    }
}